TP53 and breast cancer: Furthermore, it was reported that in human breast cancer MCF-7 cells, SST analog OCT triggered apoptosis by stimulation of a tumour suppressor protein, wild-type 53 and Bax, suggesting the potential use of SST analogs in the treatment of breast cancer cells expressing SSTRs, as well as wild-type p53 [36].